| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/05/2005 | CN1182920C Sensor for microfluid handling system |
| 01/04/2005 | US6838594 Limnanthes oil genes |
| 01/04/2005 | US6838593 Austin responsive promoter sequences and methods of using the same |
| 01/04/2005 | US6838592 Using modulators of endocytic activity to treat neuodegenerative diseases |
| 01/04/2005 | US6838560 Labeling Rna, Dna; analyzing |
| 01/04/2005 | US6838556 Promoters for regulated gene expression |
| 01/04/2005 | US6838555 Hansenula polymorpha mutants and process for the preparation of recombinant proteins using the same |
| 01/04/2005 | US6838553 Peptide repeat immunogens |
| 01/04/2005 | US6838548 Artiodactyl epimorphine |
| 01/04/2005 | US6838446 Anticancer agents; genetic engineered enzyme |
| 01/04/2005 | US6838445 Tumor antigen peptide originating in SART-1 |
| 01/04/2005 | US6838444 Using nucleic acid; repair interior ear hair |
| 01/04/2005 | US6838437 Inactivation resistant factor VIII |
| 01/04/2005 | US6838435 Grampositive, gramnegative bacteria; bactericides, fungicides; antibiotic resistance |
| 01/04/2005 | US6838433 Peptides used as inhibitors of interleukin-6 (IL-6), for prophylaxis, therapy and/or diagnosis of blood disorders such as leukemia |
| 01/04/2005 | US6838428 A non-human mammal phenotype, vectors expressing the protein for treating respiratory system disease, viral diseases, purifying SP-D antibodies, enzyme inhibitor of metalloproteinase |
| 01/04/2005 | US6838291 For identifying compounds that bind to ion channel and may have antiarrhythmic activity |
| 01/04/2005 | US6838285 Generation of adenoviral vectors; obtain nucleotide sequences, incubate with vector, expose to recombinases, recover vector |
| 01/04/2005 | US6838283 Antitumor agents |
| 01/04/2005 | US6838282 Polynucleotide that encodes a polypeptide; binding specificity; useful in bone marrow transplantation and gene therapy |
| 01/04/2005 | US6838281 Cells expressing fusion proteins of immunoglobulins |
| 01/04/2005 | US6838280 Containing iduronate-2-sulfatase gene; gene therapy |
| 01/04/2005 | US6838279 DNA having a deletion in both copies of the LAT gene and ICP34.5 gene are inserted into the malignant cell |
| 01/04/2005 | US6838276 Comprises nucleotide sequences coding chimeric oxidoreductase for identifying and screening herbicides and their targets |
| 01/04/2005 | US6838275 Human G-coupled protein receptor kinases and polynucleotides encoding the same |
| 01/04/2005 | US6838274 Urocortin proteins and uses thereof |
| 01/04/2005 | US6838273 Cloning and characterization of the FLBA gene of H. pylori, production of aflagellate strains |
| 01/04/2005 | US6838272 Filtration process for separating viruses |
| 01/04/2005 | US6838271 Comprises nucleotide sequences coding winter wheat hydrolase for transforming cells and generating snow mold resistant plants |
| 01/04/2005 | US6838270 Gene encoding protein capable of regenerating luciferin, novel recombinant DNA, and process for producing protein capable of regenerating luciferin |
| 01/04/2005 | US6838269 Comprises reduced allergenic variant of enzymatic polypeptide for use in textile treatment and cleaning composition and animal feeds; antiallergens |
| 01/04/2005 | US6838265 Overproduction hosts for biosynthesis of polyketides |
| 01/04/2005 | US6838262 Isolated DNA molecule encoding rank ligand |
| 01/04/2005 | US6838261 Nucleic acids encoding anti-CD40 proteins and methods of producing recombinant anti-CD40 proteins |
| 01/04/2005 | US6838260 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| 01/04/2005 | US6838259 Process for producing kiss-1 peptide |
| 01/04/2005 | US6838258 G protein-coupled receptor up-regulated in prostate cancer and uses thereof |
| 01/04/2005 | US6838257 Pullulanase variants and methods for preparing such variants with predetermined properties |
| 01/04/2005 | US6838254 Preparing catalytic antibodies for use as diagnostic tools in disease detection |
| 01/04/2005 | US6838240 Detection of blooms disease; obtain tissue sample, incubate with probe which hybridizes to gene associated with blooms disease, the abence of wildtype gene indicates disease |
| 01/04/2005 | US6838237 Antigenically reactive regions of the hepatitis a virus polyprotein |
| 01/04/2005 | US6838085 DNA immunization against Chlamydia infection |
| 01/04/2005 | US6838084 For connection with major histomcompatability complex molecules |
| 01/04/2005 | CA2346860C Multi-well microfiltration apparatus |
| 01/04/2005 | CA2288341C Erythropoietin in the treatment of domestic and livestock animals for anemia |
| 01/04/2005 | CA2285023C High avidity polyvalent and polyspecific reagents |
| 01/04/2005 | CA2283509C Novel bicyclonucleoside and oligonucleotide analogue |
| 01/04/2005 | CA2274982C New escherichia coli host/vector system based on antibiotic-free selection by complementation of an auxotrophy |
| 01/04/2005 | CA2222696C Virus resistant plants expressing animal cell-derived (2'-5') oligoadenylate synthetase and ribonuclease l and a method for creating the same |
| 01/04/2005 | CA2200563C Calcium free subtilisin mutants |
| 01/04/2005 | CA2145420C Cleaning compositions containing novel alkaline proteases |
| 01/04/2005 | CA2123133C Hybridization of polynucleotides conjugated with chromophores and fluorophores to generate donor-to-donor energy transfer system |
| 01/04/2005 | CA1341471C Transformation of hereditary material of plants |
| 01/04/2005 | CA1341470C Genetically engineered plant cells resistant to glutamine synthetase inhibitors |
| 01/01/2005 | CA2472846A1 Methods for assessing and treating leukemia |
| 12/30/2004 | US20040268444 Introducing exogenous genes into apical meristematic cells of embryonic axis of leguminous plants by bombarding plant cells with DNA construct for conferring herbicide resistance, inducing multiple shoot formation via culturing with cytokinin, then selecting shoots; soybeans, beans, cowpea and peanuts |
| 12/30/2004 | US20040268443 Transgenic expression of a phytochrome a gene |
| 12/30/2004 | US20040268442 Transforming tobacco cell line containing sequences encoding antigens (such as hemagglutinin/neuraminidase protein from Newcastle Disease Virus), culturing, washing, suspending in lysis buffer, disrupting cells, then separating debris; vaccines |
| 12/30/2004 | US20040268441 Short interference RNA/microRNA pathways; improved disease/herbicide resistance |
| 12/30/2004 | US20040268440 Transgenic plants expressing cobalamin binding proteins |
| 12/30/2004 | US20040268439 Genes encoding carotenoid compounds |
| 12/30/2004 | US20040268438 Isolated via connecting fragment (derived via PCR amplification, restriction endonuclease, or solid phase synthesis) upstream to a reporter gene and testing gene expression |
| 12/30/2004 | US20040268437 Method for biosynthesizing the serotonin derivatives in plants |
| 12/30/2004 | US20040268436 Method for production of C30-aldehyde carotenoids |
| 12/30/2004 | US20040268435 Cotton transcription factors and their uses |
| 12/30/2004 | US20040268434 Plant transformation |
| 12/30/2004 | US20040268433 Methods and means for modulating cellulose biosynthesis in fiber producing plants |
| 12/30/2004 | US20040268432 Method for transforming plant, the resultant plant and gene thereof |
| 12/30/2004 | US20040268431 vector for transforming a plant comprising a DNA sequence encoding a recombinant human cytokine and a promoter; hG-CSF expressed in seeds of the transgenic plant; mass production |
| 12/30/2004 | US20040268427 making the expression of a RNA transcript of a preselected cellular gene responsive to viral infection of the cell wherein the viral infection; transgenic plants and animals resistant to viral pathogens |
| 12/30/2004 | US20040268426 P2Y4 receptor transgenic and knockout non-human mammals |
| 12/30/2004 | US20040268425 use to treat glycosaminoglycan associated pathologies such as eye disorders or tumors; sialated and pegylated forms of a recombinant sHASEGP to enhance stability and serum pharmacokinetics over naturally occurring slaughterhouse enzymes; transgenic animals; dosage forms |
| 12/30/2004 | US20040268424 tissues, organs and cells for use in xenotransplantation |
| 12/30/2004 | US20040268423 inhibiting formation of neurofibrillary tangles by reducing formation of a carboxyl-terminal truncated form of apolipoprotein E (apoE) in a neuron in the individual; animal models of Alzheimer's disease (AD); treating AD; drug screening |
| 12/30/2004 | US20040268422 Methods for correcting mitotic spindle defects associated with somatic cell nuclear transfer in animals |
| 12/30/2004 | US20040267004 nucleic acid that binds to high mobility group protein-I (HMG-I), and causes presenilin-2 gene exon 5-lacked type aberrant splicing by the association with the HMG-I protein; an inhibitor for inhibiting a binding between protein-nucleic acid caused by aberrant splicing; drug screening; antisense agents |
| 12/30/2004 | US20040267003 Nucleotide and amino aicd sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro |
| 12/30/2004 | US20040267001 Genes encoding baeyer-villiger monooxygenases |
| 12/30/2004 | US20040266994 Type-1 ribosome-inactivating protein |
| 12/30/2004 | US20040266990 Cd109 nucleic acid molecules polypeptides and methods of use |
| 12/30/2004 | US20040266721 Methods and compositions for inhibiting the function of polynucleotide sequences |
| 12/30/2004 | US20040266720 Splice-region antisense composition and method |
| 12/30/2004 | US20040266718 Inhibition of specific histone deacetylase isoforms |
| 12/30/2004 | US20040266717 Administering polynucleotide capable of modulating an electrical property in a standard cardiac electrophysiological assay; expressing the polynucleotide in the mammal to prevent or treat the cardiac arrhythmia |
| 12/30/2004 | US20040266716 Administering polynucleotide capable of modulating an electrical property in a standard cardiac electrophysiological assay; expressing the polynucleotide in the mammal to prevent or treat the cardiac arrhythmia |
| 12/30/2004 | US20040266715 Neurite regeneration |
| 12/30/2004 | US20040266714 Modulate gene expression; diagnosis, therapy of disease; antidiabetic agents; insulin resistance |
| 12/30/2004 | US20040266713 Using nucleic acids; antitumor agents |
| 12/30/2004 | US20040266712 Selective inhibition of vascular smooth muscle cell proliferation |
| 12/30/2004 | US20040266711 Gene for efficiency biosynthesis; prevent food spoilage; milk from trabsgenic animal |
| 12/30/2004 | US20040266710 Immunotherapy; induce immunology response |
| 12/30/2004 | US20040266709 Immunotherapy; induction immunology response |
| 12/30/2004 | US20040266708 Rendering selected polynucleic acid molecules as targets for RNA silencing; genetically modifying cells and multi-cellular organisms to impart resistance to viruses |
| 12/30/2004 | US20040266707 Exposing a double stranded polynucleotide comprised of a sense strand and an antisense strand to a target nucleic acid, and wherein said sense strand is substantially nonfunctional |
| 12/30/2004 | US20040266706 Cross-linked oligomeric compounds and their use in gene modulation |
| 12/30/2004 | US20040266705 Hybrid nucleic acid; prevent gene expression; therapy for atherosclerosis, cardiovascular and metabolism disorders |
| 12/30/2004 | US20040266694 Angiogenesis inhibitor induced by vascular endothelial growth factor |
| 12/30/2004 | US20040266684 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 12/30/2004 | US20040266679 Isolated ucleic acid; nucleotide sequence coding protein; detection moderators of kinase peptide |
| 12/30/2004 | US20040266674 For diagnosis, therapy, prevention of cell proliferation, autoimmune disease, antiinflammatory agents, cardiovascular disorders, central nervous system disorders; isolated nucleic acids; genetic engineeringo |